ArticleCell death and differentiation2026
Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The p53-murine double minute 2 (MDM2) feedback loop plays a central role in tumor suppression by optimizing p53-dependent DNA damage responses (DDRs), though it has been suggested that factors other than MDM2 are also involved in the regulation of the p53-MDM2 feedback loop. We identified makorin ring finger protein 1 (MKRN1) as a novel ubiquitin E3 ligase that ubiquitinates MDM2 and thereby promotes the p53 activation. As previously demonstrated, MKRN1 ubiquitinates and degrades p53 under steady-state conditions. However, when DNA damage occurs, MKRN1 switches its substrate to MDM2. Thereafter, MKRN1 promotes the stabilization and activation of p53 through proteasomal degradation of MDM2, which contributes to the elimination of DNA-damaged cells. Moreover, we found that the switch in the substrate of MKRN1 was determined by the NAD(+)-dependent protein deacetylase Sirtuin-1 (SIRT1). Thus, our results suggest that MKRN1 working in conjunction with SIRT1 is a master regulator of the p53-MDM2 feedback loop modulated by crosstalk between ubiquitination and acetylation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.